UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 9, 2025 5:00 P.M.
Form:
S-3
CIK:
0001859007
Company Name:
ZyVersa Therapeutics, Inc.
File Number:
333-286396